Clinical study of autologous tumor lysate-pulsed dendritic cell therapy after resection of lung cancer.

Trial Profile

Clinical study of autologous tumor lysate-pulsed dendritic cell therapy after resection of lung cancer.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 12 May 2016

At a glance

  • Drugs HSP105 peptide-loaded dendritic cell vaccine (Primary) ; Dendritic cell vaccines
  • Indications Lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 05 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 15 Jun 2011 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
    • 15 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top